The Covid vaccine should, in the main, be allocated according to clinical need, not willingness or ability to pay, says the IEA’s Head of Political Economy, Dr Kristian Niemietz, but why shouldn’t there be a privately-available vaccine?

Kristian told the Express that“If private sales make additional resources available for the setting up of a private, additional distribution channel, then surely everyone benefits. This is not ‘jumping the queue’. This is setting up a parallel fast-track queue.”

Read the full article here.